After two decades, the FDA approves a new Alzheimer’s drug
The Food and Drug Administration (FDA) has fully approved lecanemab (Leqembi) — a drug to slow the progression of early-stage Alzheimer’s disease —making it soon available to more than a million Medicare patients.
Experts from the USC Leonard … Read More »